| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 10/10/2001 | EP1140028A1 Methods for treating ovarian cancer, poly(phosphoester) compositions, and biodegradable articles for same |
| 10/10/2001 | EP1140027A1 Dosage forms comprising porous particles |
| 10/10/2001 | EP1140026A1 Biodegradble polymer encapsulated serotonin receptor antagonist and method for preparing the same |
| 10/10/2001 | EP1140025A1 Granules for oral administration, process for producing the same, and tablets produced from the granules |
| 10/10/2001 | EP1140024A2 Particles for oral delivery of peptides and proteins |
| 10/10/2001 | EP1140023A2 Integrative protein-dna cochleate formulations and methods for transforming cells |
| 10/10/2001 | EP1140022A2 Method of administering a compound to multi-drug resistant cells |
| 10/10/2001 | EP1140021A1 Improved formulation for topical non-invasive application in vivo |
| 10/10/2001 | EP1140020A1 Large molecule drug delivery system using aerosolized membrane-mimetic amphiphiles |
| 10/10/2001 | EP1140019A1 Aerosol formulations for buccal and pulmonary application |
| 10/10/2001 | EP1140018A1 Polyol/oil suspensions for the sustained release of proteins |
| 10/10/2001 | EP1140017A1 Water-insoluble drug delivery system |
| 10/10/2001 | EP1140016A1 Composition set and kit for use in intraocular surgery |
| 10/10/2001 | EP1140015A1 Polynucleotide compositions for intramuscular and intradermal administration |
| 10/10/2001 | EP1140014A2 Osmotic delivery system having space efficient piston |
| 10/10/2001 | EP1140013A1 Foaming antacid suspension tablets |
| 10/10/2001 | EP1140012A2 Conversion of liquid filled gelatin capsules into controlled release systems by multiple coatings |
| 10/10/2001 | EP1140011A1 Pharmaceutical composition for oral administration designed to prevent misuse at the expense of a third party |
| 10/10/2001 | EP1140010A2 Substrate composition and method of use for sequestration of skin irritants |
| 10/10/2001 | EP1140009A2 Absorbent article composition and method of use for sequestering skin irritants |
| 10/10/2001 | EP1140006A1 Skin protection agents containing a fragment mixture produced from hyaluronic acid by hydrolysis |
| 10/10/2001 | EP1140005A1 Utilization of an extract of a plant of the cecropia genus |
| 10/10/2001 | EP1139994A1 Oral hygiene product containing spherical microparticles on the basis of linear water-insoluble polyglucans |
| 10/10/2001 | EP1139972A1 Dihydropyrimidines and uses thereof |
| 10/10/2001 | EP1139970A2 The process for manufacturing topical ophthalmic preparations without systemic effects |
| 10/10/2001 | EP1139913A1 Composition and formulations and their use as nociceptic, anti-anxiolytic and anabolic agents |
| 10/10/2001 | EP1139886A1 Methods and apparatus for enhancement of transdermal transport |
| 10/10/2001 | EP1139774A1 Improved release of medicament active agents from a chewing gum coating |
| 10/10/2001 | EP1139773A1 Controlling release of active agents from a chewing gum coating |
| 10/10/2001 | EP1139762A1 Hydrogen peroxide disinfectant with increased activity |
| 10/10/2001 | EP1139755A2 Method for treatment of bacterial infections with once or twice-weekly administered rifalazil |
| 10/10/2001 | EP1139753A1 Formulations for treating disease and methods of using same |
| 10/10/2001 | EP1139744A1 Exo-r-mecamylamine formulation and use in treatment |
| 10/10/2001 | EP1139743A1 Exo-s-mecamylamine formulation and use in treatment |
| 10/10/2001 | EP1030657B1 Prolamin-plant polar lipid combination, preparation method and applications |
| 10/10/2001 | EP0670718B1 Pulsatile particles drug delivery system |
| 10/10/2001 | CN1317029A Method for production of spherical microparticles consisting totally or partly of at least one water-insolute ployclucan containing branches and microparticles produced according to said method |
| 10/10/2001 | CN1316911A Compositions comprising sympathomimetic amine salts unsuitable for illegal use |
| 10/10/2001 | CN1316906A Stable liquid formulations of botulinum toxin |
| 10/10/2001 | CN1316901A The use of fumaric acid derivatives in transplant medicine |
| 10/10/2001 | CN1316900A Long time drug-sustained release preparation |
| 10/10/2001 | CN1316899A Pharmaceutical composition having improved taste |
| 10/10/2001 | CN1316898A Oral micro-emulsion composition of silybin |
| 10/10/2001 | CN1316897A Dosage form comprising liquid formulation |
| 10/10/2001 | CN1316501A Effervescent carragheenin tablet as clarifier for barley juice of beer |
| 10/10/2001 | CN1316276A Low-frequency generation wet-cloth agent |
| 10/10/2001 | CN1316271A Chewing gum for preventing decayed tooth and its preparing process |
| 10/10/2001 | CN1316264A Hongsheng plaster for treating fracture and its preparing process |
| 10/10/2001 | CN1316262A Process for preparing Chinese-medicinal tablets without decocting |
| 10/10/2001 | CN1316247A Clamycin injection and its preparing process |
| 10/10/2001 | CN1316242A High mechanical stability solid oral dosage form with slow releasing function for active composition |
| 10/10/2001 | CN1072654C Benzamide derivative, composition containing said derivative and use thereof |
| 10/10/2001 | CN1072646C Stable vitamin A. |
| 10/10/2001 | CN1072500C Medicine for treatment of arthritis and its preparing process |
| 10/10/2001 | CN1072489C Series products for preventing and curing liver disease and production technology |
| 10/10/2001 | CN1072485C Use of fumagillo and derivatives thereof for preparing medicaments against intestinal infections |
| 10/10/2001 | CN1072484C Method for making tablet and granulate containing sodium 2-mercaptoethanesulfonate |
| 10/10/2001 | CN1072483C Stable, ingestabl and absorbadle NADH and NADPH therapeutic compositions |
| 10/10/2001 | CN1072482C Low-molecular heparin liposome spray preparation and its preparation technology |
| 10/09/2001 | US6300504 Use of water-soluble/dispersible reactive derivatives of polyimido compounds for modifying proteinaceous substrates |
| 10/09/2001 | US6300470 Amino acid sequence for the treatment of inflammatory pathology; microbiocides |
| 10/09/2001 | US6300458 High molecular weight polymers and copolymers of BHMDO for biomedical application |
| 10/09/2001 | US6300443 Process for preparing polymeric microgels |
| 10/09/2001 | US6300442 Heating vinyl monomer with oil as solvent to polymerize, also containing free radical catalyst and optional crosslinker, agitaing under inert gas, adding water to form emulsion |
| 10/09/2001 | US6300362 Adding glycine hydrochloride or alanine hydrochloride or valine hydrochloride to angiotensin converting enzyme inhibitor compound for stabilization |
| 10/09/2001 | US6300361 Adding betaine hydrochloride to angiotensin converting enzyme inhibitor compound for stabilization |
| 10/09/2001 | US6300332 Methods for reducing respiratory depression and attendant side effects of mu opioid compounds |
| 10/09/2001 | US6300326 Composition and method for control and treatment of cutaneous inflammation |
| 10/09/2001 | US6300322 Water solution with hydroxyethyl starch, sodium ion, chloride ion, potassium iion and calcium ion for plasma substitution |
| 10/09/2001 | US6300321 Compounds, preparation and use for transferring nucleic acids into cells |
| 10/09/2001 | US6300317 Eukarotic cells, polynucleotide, functional agents, membrane permeability, subcellar localization agents and polynucleotide masking agents |
| 10/09/2001 | US6299980 One step lubricious coating |
| 10/09/2001 | US6299925 Effervescent green tea extract formulation |
| 10/09/2001 | US6299906 Process for making submicron particles |
| 10/09/2001 | US6299905 Can be molded to fit a repair site, when used for bone/implant fixation, or as a filler for bone or cartilage repair, matrix allows it to be replaced with developing bone or cartilage tissue, can be used for release of bioactive agent |
| 10/09/2001 | US6299904 Capable of buccal disintegration or dissolution |
| 10/09/2001 | US6299903 Delayed release pharmaceutical formulation containing a β-lactam antibiotic |
| 10/09/2001 | US6299900 Non-occlusive, percutaneous or transdermal drug delivery system |
| 10/09/2001 | US6299899 Extremely flexible plaster acting dermally or transdermally, and method for producing same |
| 10/09/2001 | US6299897 Attaching selectin binding carbohydrate to a cross-linkable lipid; attaching an acidic group to a cross linkable lipid; forming lipids into sheet; crosslinking lipids |
| 10/09/2001 | US6299896 Multi-vitamin and mineral supplement |
| 10/09/2001 | US6299895 Implanting capsule periocularly in sub-tension's space, capsule comprising core containing cellular source of biologically active molecule surrounded by biocompatible jacket for delivering biologically active molecule to eye |
| 10/09/2001 | US6299894 Drug delivery device, especially for the delivery of gestodene |
| 10/09/2001 | US6299888 Azelastine hydrochloride-containing percutaneous preparation having good percutaneous absorbability and reduced skin irritation |
| 10/09/2001 | US6299885 External preparations containing watercress extract |
| 10/09/2001 | US6299884 Administering antigen to animal inpresence of an immunostimulating amount of an adjuvant formulation consisting of metabolizabel oil and emulsifier for increasing immune response to antigen |
| 10/09/2001 | US6299867 Adsorbent |
| 10/09/2001 | US6299863 Aerosol formulations containing micronized optically pure (R,R) formoterol for bronchodilating therapy |
| 10/09/2001 | US6299605 Pack for the nose |
| 10/09/2001 | CA2325541C Extended release formulations of erythromycin derivatives |
| 10/09/2001 | CA2317126C Container for an inhalation anesthetic |
| 10/09/2001 | CA2203513C Liposome composition containing selegilin |
| 10/09/2001 | CA2142320C Sustained release tablets containing bupropion |
| 10/09/2001 | CA2095354C Method and composition for controlled delivery of biologically active agents |
| 10/09/2001 | CA2085255C Polyurethane-biopolymer composite |
| 10/09/2001 | CA1341304C Pharmaceutical composition for the prevention of sexually transmitted diseases |
| 10/06/2001 | CA2343259A1 A process for producing solid creatine dosage forms and dosage forms obtainable thereby |
| 10/05/2001 | CA2303481A1 Pharmaceutical compositions comprising moexipril magnesium |
| 10/04/2001 | WO2001073431A2 Biomedical assay device |
| 10/04/2001 | WO2001072669A2 Therapeutic use of polyhydroxy amine derivates |